This 2½-day conference features more than 1,500 presentations that emphasize basic, clinical and translational sciences as they evolve toward a more complete understanding of stroke pathophysiology with the overall goal of developing more effective prevention and treatment.

Sessions in clinical categories will center on stroke community risk factors, emergency care, acute neuroimaging, endovascular and nonendovascular treatment, diagnosis, cerebrovascular occlusive disease, in-hospital treatment, and outcomes of stroke.

This conference provides the opportunity to network with more than 4,500 cerebrovascular experts representing over 60 countries; it offers outstanding programming that delivers more than 1,500 compelling presentations in 21 categories emphasizing basic, clinical and translational sciences as they evolve toward a more complete understanding of stroke pathophysiology with the goal to develop more effective prevention and treatment.

t the conclusion of the International Stroke Conference, participants should be able to:

• Identify recent advances in basic models of stroke and translational research.

• Evaluate recent advances in the diagnosis, treatment, prevention and rehabilitation of cerebrovascular disease.

• Analyze new and ongoing clinical research advances through late-breaking science and ongoing clinical trials sessions.

• Communicate in the interactive exchange of new research, treatment and intervention with scientists and investigators working in all areas of cerebrovascular disease.

• Interpret the rapidly changing areas within the stroke spectrum such as emerging options for the diagnosis and treatment of acute stroke, mechanisms of stroke recovery, and the impact of vascular cognitive impairment.

• Appraise the diverse challenges presented by cerebrovascular disease to specific populations, including ethnic and racial minorities, women, children, and developing communities.